NCT01310829

Brief Summary

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel patients regarding cancer genetics.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2011

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 7, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 9, 2011

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

May 26, 2016

Status Verified

May 1, 2016

Enrollment Period

5.2 years

First QC Date

March 7, 2011

Last Update Submit

May 24, 2016

Conditions

CancerPrevention Harmful Effects

Keywords

Genetic counselorGenetic counseling degree programGenetic counseling studentsVirtual reality-based interventionVRGenetic counselinghereditary cancersQuestionnairesPhysiological measurementsSkin sensors

Outcome Measures

Primary Outcomes (1)

  • Proof of concept for Virtual Reality (VR) Technology as Training Method About Hereditary cancer risk and genetic testing

    Proof of concept for VR application established if VR prototype successfully evokes a sense of presence and co-presence (measured by the PQ and CPQ questionnaires, respectively). Responses to the PQ and CPQ given on a 7-point scale, with higher scores indicating higher degrees of presence and co-presence where mean scores above 4 considered high degree of presence and co-presence.

    2 hours

Study Arms (1)

Virtual Reality

Board-eligible or board-certified genetic counselors and students evaluate a virtual reality-based intervention using questionnaires and physiological measurements.

Behavioral: QuestionnairesBehavioral: Physiological MeasurementsBehavioral: Virtual Reality Scene Viewing

Interventions

QuestionnairesBEHAVIORAL

Questionnaires completed before and after viewing virtual reality scenes, taking about 30 minutes to complete.

Also known as: Survey
Virtual Reality
Physiological MeasurementsBEHAVIORAL

Small sensors applied to skin will measure heart rate and sweat amounts while participants view a virtual reality scene.

Virtual Reality
Virtual Reality Scene ViewingBEHAVIORAL

Prototype virtual reality application that demonstrates a provider-patient communication scenario commonly encountered in genetic counseling for hereditary cancers.

Also known as: VR technology
Virtual Reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Genetic counselors and genetic counseling students

You may qualify if:

  • Genetic counselors: Board-eligible or board-certified genetic counselor
  • Genetic counseling students: Currently enrolled and in good standing in an accredited genetic counseling degree program
  • years of age or older

You may not qualify if:

  • \. Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Susan Peterson, PHD, MPH

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2011

First Posted

March 9, 2011

Study Start

February 1, 2011

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

May 26, 2016

Record last verified: 2016-05